Jacob Chacko - Net Worth and Insider Trading
Jacob Chacko Net Worth
The estimated net worth of Jacob Chacko is at least $7 Million dollars as of 2024-04-27. Jacob Chacko is the PRESIDENT AND CEO of ORIC Pharmaceuticals Inc and owns about 728,544 shares of ORIC Pharmaceuticals Inc (ORIC) stock worth over $6 Million. Jacob Chacko is the CFO of Ignyta Inc and owns about 42,838 shares of Ignyta Inc (RXDX) stock worth over $1 Million. Jacob Chacko is also the Director of 4D Molecular Therapeutics Inc and owns about 0 shares of 4D Molecular Therapeutics Inc (FDMT) stock worth over $0. Details can be seen in Jacob Chacko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jacob Chacko has not made any transactions after 2024-03-06 and currently still holds the listed stock(s).
Transaction Summary of Jacob Chacko
Jacob Chacko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jacob Chacko owns 4 companies in total, including Turning Point Therapeutics Inc (TPTX) , ORIC Pharmaceuticals Inc (ORIC) , and Ignyta Inc (RXDX) among others .
Click here to see the complete history of Jacob Chacko’s form 4 insider trades.
Insider Ownership Summary of Jacob Chacko
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TPTX | Turning Point Therapeutics Inc | 2019-04-16 | director |
| ORIC | ORIC Pharmaceuticals Inc | 2024-03-06 | director & President and CEO |
| RXDX | Ignyta Inc | 2018-02-08 | Chief Financial Officer |
| FDMT | 4D Molecular Therapeutics Inc | 2023-04-21 | director |
Jacob Chacko Latest Holdings Summary
Jacob Chacko currently owns a total of 3 stocks. Among these stocks, Jacob Chacko owns 728,544 shares of ORIC Pharmaceuticals Inc (ORIC) as of March 6, 2024, with a value of $6 Million and a weighting of 83.59%. Jacob Chacko owns 42,838 shares of Ignyta Inc (RXDX) as of March 17, 2016, with a value of $1 Million and a weighting of 16.41%. Jacob Chacko also owns 0 shares of 4D Molecular Therapeutics Inc (FDMT) as of April 21, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Jacob Chacko
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ORIC | ORIC Pharmaceuticals Inc | 2024-03-06 | 728,544 | 8.07 | 5,879,350 |
| RXDX | Ignyta Inc | 2016-03-17 | 42,838 | 26.95 | 1,154,484 |
| FDMT | 4D Molecular Therapeutics Inc | 2023-04-21 | 0 | 23.25 | 0 |
Holding Weightings of Jacob Chacko
Jacob Chacko Form 4 Trading Tracker
According to the SEC Form 4 filings, Jacob Chacko has made a total of 15 transactions in ORIC Pharmaceuticals Inc (ORIC) over the past 5 years, including 2 buys and 13 sells. The most-recent trade in ORIC Pharmaceuticals Inc is the sale of 40,000 shares on March 6, 2024, which brought Jacob Chacko around $648,400.
According to the SEC Form 4 filings, Jacob Chacko has made a total of 0 transactions in Ignyta Inc (RXDX) over the past 5 years. The most-recent trade in Ignyta Inc is the acquisition of 10,000 shares on March 17, 2016, which cost Jacob Chacko around $56,400.
According to the SEC Form 4 filings, Jacob Chacko has made a total of 1 transactions in 4D Molecular Therapeutics Inc (FDMT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in 4D Molecular Therapeutics Inc is the sale of 5,000 shares on April 21, 2023, which brought Jacob Chacko around $100,250.
Insider Trading History of Jacob Chacko
- 1
Jacob Chacko Trading Performance
GuruFocus tracks the stock performance after each of Jacob Chacko's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jacob Chacko is 2.89%. GuruFocus also compares Jacob Chacko's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jacob Chacko within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jacob Chacko's insider trading performs compared to the benchmark.
Performance of Jacob Chacko
Average Return
11.32%
Outperforming Transactions
60%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.88 | 2.89 | -21.71 | 11.32 | 23 | |
| Relative Return to S&P 500(%) | 26.56 | 4.02 | -17.67 | 6.8 | 13.02 |
Jacob Chacko Ownership Network
Ownership Network List of Jacob Chacko
Ownership Network Relation of Jacob Chacko
Jacob Chacko Owned Company Details
What does Turning Point Therapeutics Inc do?
Who are the key executives at Turning Point Therapeutics Inc?
Jacob Chacko is the director of Turning Point Therapeutics Inc. Other key executives at Turning Point Therapeutics Inc include EVP & Chief Financial Officer Paolo Tombesi , SVP & Chief Commercial Officer Steve M Sabus , and SVP & General Counsel Brian Sun .
Turning Point Therapeutics Inc (TPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Turning Point Therapeutics Inc Insider Transactions
Jacob Chacko Mailing Address
Above is the net worth, insider trading, and ownership report for Jacob Chacko. You might contact Jacob Chacko via mailing address: C/o Ignyta, Inc., 11095 Flintkote Ave., Suite D, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
